Application no. and date | 17702951.9 (espacenet) (Federated) (European Patent Register), 20170116 | Patent/reg. no. and date | DK/EP 3405212, 20200708 | Publication date | 20181128 | Priority no. and date | US 201662280636 P, 20160119, US 201662419190 P, 20161108 | EP pub. no. and date |
EP 3405212 20181128 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | V48737DK00 | Inventor | BINDER, Joseph John, 12282 Cornwallis Square
San Diego, CA 92128, US, CHO, Helen Kim, 4127 Twilight Ridge
San Diego, CA 92130, US, JOOSS, Karin Ute, 3712 Garden Lane
San Diego, CA 92106, US, COCKLE, Paul Jason, 126 Redwood Road
San Anselmo, CA 94960, US, FALCONER, Derek John, 4651 Torrey Circle Apt. K302
San Diego, CA 92130, US, GURU, Siradanahalli, 10515 Abalone Landing Terrace
San Diego, CA 92130, US, MARTINIC, Marianne Marcela Andrea, 8623 Via Mallorca Unit C
La Jolla, CA 92037, US, WILLS, Kenneth Nelson, 7806 Via Opuntia
Carlsbad, CA 92009, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/00 (2006.01) | Title | Cancervacciner | Int. application no. | IB2017050229 | Int. publication no. | WO2017125844 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|